Northern Trust’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-81,124
| Closed | -$35.9K | – | 4678 |
|
|
2023
Q1 | $35.9K | Sell |
81,124
-1,019
| -1% | -$399 | ﹤0.01% | 4338 |
|
|
2022
Q4 | $18K | Hold |
82,143
| – | – | ﹤0.01% | 4507 |
|
|
2022
Q3 | $30K | Hold |
82,143
| – | – | ﹤0.01% | 4467 |
|
|
2022
Q2 | $53K | Hold |
82,143
| – | – | ﹤0.01% | 4398 |
|
|
2022
Q1 | $67K | Sell |
82,143
-1,097
| -1% | -$1.02K | ﹤0.01% | 4463 |
|
|
2021
Q4 | $95K | Sell |
83,240
-602
| -0.7% | -$1.23K | ﹤0.01% | 4439 |
|
|
2021
Q3 | $210K | Buy |
83,842
+6,051
| +8% | +$16.8K | ﹤0.01% | 4156 |
|
|
2021
Q2 | $231K | Sell |
77,791
-166,799
| -68% | -$581K | ﹤0.01% | 4097 |
|
|
2021
Q1 | $858K | Sell |
244,590
-47,328
| -16% | -$264K | ﹤0.01% | 3647 |
|
|
2020
Q4 | $1.39M | Sell |
291,918
-10,507
| -3% | -$54.3K | ﹤0.01% | 3371 |
|
|
2020
Q3 | $1.47M | Buy |
302,425
+136,358
| +82% | +$646K | ﹤0.01% | 3210 |
|
|
2020
Q2 | $539K | Buy |
166,067
+120,583
| +265% | +$1.14M | ﹤0.01% | 3535 |
|
|
2020
Q1 | $233K | Buy |
45,484
+1,346
| +3% | +$5.45K | ﹤0.01% | 3645 |
|
|
2019
Q4 | $201K | Sell |
44,138
-83,647
| -65% | -$408K | ﹤0.01% | 3798 |
|
|
2019
Q3 | $783K | Buy |
127,785
+79,013
| +162% | +$471K | ﹤0.01% | 3453 |
|
|
2019
Q2 | $297K | Hold |
48,772
| – | – | ﹤0.01% | 3700 |
|
|
2019
Q1 | $271K | Sell |
48,772
-5,096
| -9% | -$33.1K | ﹤0.01% | 3704 |
|
|
2018
Q4 | $305K | Buy |
53,868
+17,258
| +47% | +$127K | ﹤0.01% | 3668 |
|
|
2018
Q3 | $384K | Buy |
36,610
+13,416
| +58% | +$144K | ﹤0.01% | 3687 |
|
|
2018
Q2 | $257K | Buy |
23,194
+3,159
| +16% | +$28.4K | ﹤0.01% | 3775 |
|
|
2018
Q1 | $160K | Buy |
20,035
+1,300
| +7% | +$10.4K | ﹤0.01% | 3876 |
|
|
2017
Q4 | $154K | Buy |
18,735
+2
| +0% | +$14 | ﹤0.01% | 3887 |
|
|
2017
Q3 | $116K | Hold |
18,733
| – | – | ﹤0.01% | 3924 |
|
|
2017
Q2 | $113K | Hold |
18,733
| – | – | ﹤0.01% | 3947 |
|
|
2017
Q1 | $99K | Buy |
18,733
+4,436
| +31% | +$25.8K | ﹤0.01% | 3955 |
|
|
2016
Q4 | $97K | Buy |
14,297
+95
| +0.7% | +$658 | ﹤0.01% | 3909 |
|
|
2016
Q3 | $105K | Hold |
14,202
| – | – | ﹤0.01% | 3886 |
|
|
2016
Q2 | $116K | Buy |
14,202
+4,002
| +39% | +$31.2K | ﹤0.01% | 3859 |
|
|
2016
Q1 | $61K | Sell |
10,200
-37,665
| -79% | -$194K | ﹤0.01% | 3994 |
|
|
2015
Q4 | $255K | Buy |
47,865
+37,665
| +369% | +$189K | ﹤0.01% | 3684 |
|
|
2015
Q3 | $41K | Buy |
+10,200
| New | +$46.1K | ﹤0.01% | 4112 |
|
|
2014
Q3 | – | Sell |
-16,431
| Closed | -$57K | – | 4428 |
|
|
2014
Q2 | $57K | Buy |
+16,431
| New | +$52.8K | ﹤0.01% | 4095 |
|
Other funds holding CEMI
Northern Trust's CEMI Position: Q2 2023 in Review
Northern Trust sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 81,124 shares — an estimated $35.9K sold.
Northern Trust first reported a position in CEMI in Q2 2014 and held it in 32 quarters. The position peaked at $1.47M in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Northern Trust reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Northern Trust sold 81,124 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $35.9K.
- Northern Trust first reported a position in Chembio diagnostics, Inc. in Q2 2014 and held it in 32 quarters.
- Northern Trust's Chembio diagnostics, Inc. position peaked at $1.47M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.